1. Home
  2. ORMP vs MDXH Comparison

ORMP vs MDXH Comparison

Compare ORMP & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • MDXH
  • Stock Information
  • Founded
  • ORMP 2002
  • MDXH 2003
  • Country
  • ORMP United States
  • MDXH Belgium
  • Employees
  • ORMP N/A
  • MDXH N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • MDXH
  • Sector
  • ORMP Health Care
  • MDXH
  • Exchange
  • ORMP Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • ORMP 90.7M
  • MDXH 93.1M
  • IPO Year
  • ORMP N/A
  • MDXH 2021
  • Fundamental
  • Price
  • ORMP $2.17
  • MDXH $1.86
  • Analyst Decision
  • ORMP Hold
  • MDXH Strong Buy
  • Analyst Count
  • ORMP 1
  • MDXH 2
  • Target Price
  • ORMP N/A
  • MDXH $7.00
  • AVG Volume (30 Days)
  • ORMP 113.9K
  • MDXH 112.7K
  • Earning Date
  • ORMP 03-05-2025
  • MDXH 02-26-2025
  • Dividend Yield
  • ORMP N/A
  • MDXH N/A
  • EPS Growth
  • ORMP N/A
  • MDXH N/A
  • EPS
  • ORMP 0.11
  • MDXH N/A
  • Revenue
  • ORMP N/A
  • MDXH $84,708,000.00
  • Revenue This Year
  • ORMP N/A
  • MDXH $28.76
  • Revenue Next Year
  • ORMP N/A
  • MDXH $19.91
  • P/E Ratio
  • ORMP $19.82
  • MDXH N/A
  • Revenue Growth
  • ORMP N/A
  • MDXH 33.01
  • 52 Week Low
  • ORMP $2.00
  • MDXH $1.55
  • 52 Week High
  • ORMP $3.67
  • MDXH $3.85
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 36.05
  • MDXH 33.28
  • Support Level
  • ORMP $2.12
  • MDXH $1.80
  • Resistance Level
  • ORMP $2.27
  • MDXH $1.97
  • Average True Range (ATR)
  • ORMP 0.07
  • MDXH 0.07
  • MACD
  • ORMP -0.01
  • MDXH -0.01
  • Stochastic Oscillator
  • ORMP 22.73
  • MDXH 12.50

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Share on Social Networks: